Compass news archive
Read our latest news and updates.
For media inquiries, contact us at media@compasspathways.com
-
February 16, 2023
Compass’s impact strategy
Read article
-
February 10, 2023
Celebrating the International Day of Women and Girls in Science
Read article
-
January 25, 2023
Supporting parents at work
Read article
-
December 15, 2022
Our holiday traditions and reflections
Read article
-
December 08, 2022
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented...
Read article
-
December 01, 2022
Pursuing passions: on playing Horseball for Great Britain
Read article
-
November 03, 2022
Compass Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
Read article
-
November 03, 2022
Compass Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment...
Read article
-
October 27, 2022
Compass Pathways plc to announce third quarter 2022 financial results on 3 November 2022
Read article
-
October 12, 2022
Compass Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depres...
Read article
-
October 10, 2022
What it’s like to live with treatment-resistant depression
Read article
-
October 04, 2022
Compass Pathways to Hold Virtual Capital Market Day on 12 October 2022
Read article
-
September 29, 2022
GetReal Institute: the importance of real world evidence
Read article
-
August 04, 2022
Compass Pathways plc announces second quarter 2022 financial results and business highlights
Read article
-
August 02, 2022
Compass Pathways Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pur...
Read article
-
July 28, 2022
Compass Pathways launches phase 2 clinical trial of psilocybin therapy in anorexia nervosa
Read article
-
July 19, 2022
Compass Pathways appoints Kabir Nath as Chief Executive Officer
Read article
-
July 19, 2022
Letter from Kabir Nath, our new CEO from August 1, 2022
Read article
-
June 15, 2022
Sound Mind Live: the power of music
Read article
-
May 23, 2022
Compass Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Associat...
Read article
-
May 10, 2022
Compass Pathways plc announces first quarter 2022 financial results and business highlights
Read article
-
May 09, 2022
Compass Pathways to fund study of COMP360 psilocybin in autistic adults
Read article
-
May 03, 2022
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa an...
Read article
-
April 20, 2022
Compass Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental...
Read article
-
March 24, 2022
Compass Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
Read article
-
March 08, 2022
Our annual review 2021
Read article
-
February 24, 2022
Compass Pathways announces financial results for the fourth quarter and full year 2021 and business ...
Read article
-
January 24, 2022
Meet Evie, a neuroscientist and BNA Scholar
Read article
-
January 19, 2022
Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with...
Read article
-
January 04, 2022
A New Year message to our community
Read article